The role of BHLHE40 in clinical features and prognosis value of PDAC by comprehensive analysis and in vitro validation
Pancreatic ductal adenocarcinoma (PDAC) is the leading cause of cancer-related mortality, primarily due to the abundance of cancer-associated fibroblasts (CAFs), depleted effector T cells, and increased tumor cell stemness; hence, there is an urgent need for efficient biomarkers with prognostic and...
Main Authors: | Chao Liu, Jiang Du, Jianwei Zheng, Ruizhe Zhang, Jialin Zhu, Bofan Xing, Lin Dong, Qianqian Zhou, Xiaofeng Yao, Song Gao, Yu Wang, Yu Ren, Xuan Zhou |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-06-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2023.1151321/full |
Similar Items
-
BHLHE40 promotes osteoclastogenesis and abnormal bone resorption via c-Fos/NFATc1
by: Yufeng Zhang, et al.
Published: (2022-05-01) -
BHLHE40 Inhibits Ferroptosis in Pancreatic Cancer Cells via Upregulating SREBF1
by: Yizhi Cao, et al.
Published: (2024-02-01) -
BHLHE40 confers a pro-survival and pro-metastatic phenotype to breast cancer cells by modulating HBEGF secretion
by: Aarti Sethuraman, et al.
Published: (2018-10-01) -
17β-Estradiol Inhibits Proliferation and Oxidative Stress in Vascular Smooth Muscle Cells by Upregulating BHLHE40 Expression
by: Dan-dan Feng, et al.
Published: (2021-11-01) -
Cardiac-specific knockdown of Bhlhe40 attenuates angiotensin II (Ang II)-Induced atrial fibrillation in mice
by: Kai-Wen Ren, et al.
Published: (2022-10-01)